With its newly launched predictive analytics platform, Real Chemistry is hoping to “shine a light” on the GLP-1 agonist ...

Just about two months into his CEO job at Emergent BioSolutions, Joseph Papa has laid out his turnaround plan for the ...

Amid a U.S. biosecurity crackdown targeting certain Chinese manufacturers and contract research organizations, production ...

Thanks to a new reorganization plan, Johnson & Johnson is on the cusp of settling more than 50,000 lawsuits linking its ...

Even with the threat of a potential new competitor in the respiratory syncytial virus (RSV) vaccine race on the horizon, GSK ...

Following the lead of Eli Lilly, Pfizer will establish a direct-to-consumer service, selling some of its medicines online and ...

It’s no secret that U.S. biopharma companies rely on Chinese contractors to provide lab research and drug manufacturing ...

The U.S. Federal Trade Commission (FTC) is not done with its crackdown on what it views as improper listing of patents with ...

Physicians are unequivocal about who is the big kahuna in the vaccine industry. | Physicians are unequivocal about who is the ...

While an ongoing production expansion push for Eli Lilly's popular tirezeptide-based medicines Mounjaro and Zepbound should ...

Johnson & Johnson is unveiling a new look as part of its British birthday bash. | Johnson & Johnson is unveiling a new look ...

Moderna has launched a new video series to energize its social media followers’ midafternoon breaks. | No 2 p.m. slump ...